Literature DB >> 34166752

From bumblebee to bioeconomy: Recent developments and perspectives for sophorolipid biosynthesis.

Sven Dierickx1, Martijn Castelein2, Jelle Remmery3, Veerle De Clercq4, Sofie Lodens5, Niki Baccile6, Sofie L De Maeseneire7, Sophie L K W Roelants8, Wim K Soetaert9.   

Abstract

Sophorolipids are biobased compounds produced by the genera Starmerella and Pseudohyphozyma that gain exponential interest from academic and industrial stakeholders due to their mild and environmental friendly characteristics. Currently, industrially relevant sophorolipid volumetric productivities are reached up to 3.7 g∙L-1∙h-1 and sophorolipids are used in the personal care and cleaning industry at small scale. Moreover, applications in crop protection, food, biohydrometallurgy and medical fields are being extensively researched. The research and development of sophorolipids is at a crucial stage. Therefore, this work presents an overview of the state-of-the-art on sophorolipid research and their applications, while providing a critical assessment of scientific techniques and standardisation in reporting. In this review, the genuine sophorolipid producing organisms and the natural role of sophorolipids are discussed. Subsequently, an evaluation is made of innovations in production processes and the relevance of in-situ product recovery for process performance is discussed. Furthermore, a critical assessment of application research and its future perspectives are portrayed with a focus on the self-assembly of sophorolipid molecules. Following, genetic engineering strategies that affect the sophorolipid physiochemical properties are summarised. Finally, the impact of sophorolipids on the bioeconomy are uncovered, along with relevant future perspectives.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sophorolipid; Starmerella; application research; bioeconomy; biosurfactants; genetic engineering; natural role; process engineering; self-assembly

Mesh:

Substances:

Year:  2021        PMID: 34166752     DOI: 10.1016/j.biotechadv.2021.107788

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  2 in total

1.  Sophorolipid Suppresses LPS-Induced Inflammation in RAW264.7 Cells through the NF-κB Signaling Pathway.

Authors:  Ruiqi Xu; Ling Ma; Timson Chen; Jing Wang
Journal:  Molecules       Date:  2022-08-08       Impact factor: 4.927

Review 2.  Sophorolipids-Bio-Based Antimicrobial Formulating Agents for Applications in Food and Health.

Authors:  Wei Yan Cho; Jeck Fei Ng; Wei Hsum Yap; Bey Hing Goh
Journal:  Molecules       Date:  2022-08-29       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.